Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 5,723 shares at $26.02 ($149K) on 2022-09-19, disclosed to the SEC on 2022-09-21.
Open-market sale of $149k PCVX by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.02 | 2,623 | $68K | 45.8% |
| 2 | $26.02 | 2,623 | $68K | 45.8% |
| 3 | $26.52 | 477 | $13K | 8.5% |
| Total | $26.06 avg | 5,723 | $149K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |